An oncologist and leader in biotechnology, Susan Desmond-Hellmann is currently Chancellor of the University of California San Francisco. Prior to joining UCSF, Desmond-Hellmann spent 14 years at Genentech where she served as President, Product Development from 2004-2009. Under her direction, Genentech became the nation’s No. 1 producer of anti-cancer drug treatments.
Talks with this Speaker
Drug Development – the Herceptin Story
Susan Desmond-Hellmann discusses the drug development process and shares her experience with developing the targeted cancer therapeutic, Herceptin. (Talk recorded in June 2011)
Audience:
- General Public
- Student
- Researcher
- H. School / Intro Undergrad
- Adv. Undergrad / Grad
Duration: 12:43
